Wedbush Starts Spring Works Therapeutics (SWTX) at Outperform
- U.S. stocks, dollar sluggish, all eyes on Fed meet this week
- Tesla (TSLA) Tops Q2 EPS by 49c, Revenues Beat
- Chinese Tech Stocks Crushed on Fresh Regulatory Pressure
- Nearly $1 Billion Bitcoin (BTC) Shorts Liquidated Today Amid Amazon (AMZN) Rumors
- Aon (AON) and Willis Towers Watson (WLTW) Mutually Agree to Terminate Combination Agreement
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Wedbush analyst David Nierengarten initiates coverage on Spring Works Therapeutics (NASDAQ: SWTX) with a Outperform rating and a price target of $33.00.
Shares of Spring Works Therapeutics closed at $18.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Guggenheim Starts Wendy's (WEN) at Buy
- BTIG Starts Electric Last Mile Solutions Inc. (ELMS) at Buy
- UPDATE: Guggenheim Starts McDonald's (MCD) at Buy, Best Idea
Create E-mail Alert Related CategoriesNew Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!